Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > New tweet

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Jan 15, 2021 10:48am

177 Views

Post# 32305692

RE:New tweet

JohnFriesen wrote: https://twitter.com/SironaBiochem/status/1350017603285241856

But the response is more to the point;

" When do you finally gain some traction and get TFC-1067 out there into a product and to the customer? Im waiting for years and years and all I can see is one smoke-screen after another..."

Maybe it's the tweet that makes it the only green item on my list of 30 this morning. Not a lot but it's green.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”